Yasuo Yoshimi

Prof. Yasuo Yoshimi

Shibaura Institute of Technology
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2013 in The Analyst
Verified
Journal Article
Closed access
PDF file
Yasuo YoshimiYasuo Yoshimi
Yasuo Yoshimi
KSKuniaki Sato
Kuniaki Sato
MOMasaki Ohshima
Masaki Ohshima
Elena PiletskaElena Piletska
Elena Piletska
Heparin is the most important anticoagulant drug used during surgeries and extracorporeal therapies. Although the blood levels of heparin should be monitored continuously during the procedure to ensure the safety of the patient, there is currently no technique for measuring heparin in real time. This study describes the use of a molecularly imprinted polymer (MIP) as a recognition element in the development of a heparin sensor for real-time monitoring. An indium tin oxide (ITO) electrode grafted with a heparin-specific MIP was used as a working electrode to perform cyclic voltammetry of ferrocyanide. The anodic current was found to be dependent on heparin concentration, probably due to the “gate effect”, which is a change in the accessibility of the MIP-modified electrode to ferrocyanide, triggered by specific interaction between MIP and heparin. The kinetics of heparin interaction with the MIP-grafted electrode was evaluated using potentiostatic chronoamperometry of ferrocyanide in an electrochemical flow cell. The response time to stepwise changes in heparin concentration between 0 and 0.04 units per mL was estimated at 20 s, which is remarkably shorter than that achieved using conventional methods for monitoring heparin. The MIP-grafted electrode demonstrated exceptional sensitivity and could detect heparin in whole blood samples (0–6 units per mL) diluted 100-fold with physiological saline containing ferrocyanide. Therefore, the MIP-grafted electrode is suitable for real-time monitoring of heparin in blood. Another advantage is that a very small volume of blood is needed, which is very important, especially when regular measurements are required.

25 December 2009 in Journal of Artificial Organs
Verified
Journal Article
Closed access
PDF file
Yasuo YoshimiYasuo Yoshimi
Yasuo Yoshimi
ANAkisato Narimatsu
Akisato Narimatsu
KNKeisuke Nakayama
Keisuke Nakayama
SSShinichi Sekine
Shinichi Sekine
KHKoji Hattori
Koji Hattori
KSKiyotaka Sakai
Kiyotaka Sakai

15 November 2007 in Sensors and Actuators B: Chemical
Verified
Journal Article
Closed access
SSShinichi Sekine
Shinichi Sekine
YWYuta Watanabe
Yuta Watanabe
Yasuo YoshimiYasuo Yoshimi
Yasuo Yoshimi
KHKoji Hattori
Koji Hattori
KSKiyotaka Sakai
Kiyotaka Sakai

16 October 2020 in Sensors
Verified
Journal Article
Open access
PDF file
AAAaryashree Aaryashree
Aaryashree Aaryashree
ユ武ユウト 武田
ユウト 武田
MKMomoe Kanai
Momoe Kanai
AHAkihiko Hatano
Akihiko Hatano
Yasuo YoshimiYasuo Yoshimi
Yasuo Yoshimi
MKMasahito Kida
Masahito Kida
An inexpensive disposable electrochemical drug sensor for the detection of drugs (vancomycin, meropenem, theophylline, and phenobarbital) is described. Molecularly imprinted polymer (MIP) templated with the target drugs was immobilized on the surface of graphite particles using a simple radical polymerization method and packed into the working electrode of a three-electrode ceramic-based chip sensor. Differential pulse voltammetry (DPV) was used to determine the relationship between the response current and the concentration of the targeted drug while using one sensor chip for one single operation. The time required for each DPV measurement was less than 2 min. Concentrations corresponding to the therapeutic range of these drugs in plasma were taken into account while performing DPV. In all the cases, the single-used MIP sensor showed higher sensitivity and linearity than non-imprinted polymer. The selectivity test in drugs with a structure similar to that of the target drugs was performed, and it was found that MIP-based sensors were more selective than the untreated ones. Additionally, the test in whole blood showed that the presence of interfering species had an insignificant effect on the diagnostic responses of the sensor. These results demonstrate that the disposable MIP-sensor is promising for quick and straightforward therapeutic drug monitoring to prevent the toxic side effects and the insufficient therapeutic effect due to the overdose and underdose, respectively.

20 March 2023 in Sensors
Verified
Journal Article
Open access
PDF file
AAAaryashree Aaryashree
Aaryashree Aaryashree
ACAshish Kumar Choudhary
Ashish Kumar Choudhary
Yasuo YoshimiYasuo Yoshimi
Yasuo Yoshimi
Epilepsy is a neurological disorder that affects millions of people worldwide. Anti-epileptic drugs (AEDs) are critical for their management. However, the therapeutic window is narrow, and traditional laboratory-based therapeutic drug monitoring (TDM) methods can be time consuming and unsuitable for point-of-care testing. To address this issue, we developed a disposable sensor chip based on molecularly imprinted polymer-modified carbon paste electrodes (MIP-CPs) for the TDM of AEDs such as phenobarbital (PB), carbamazepine (CBZ), and levetiracetam (LEV). In this work, functional monomers (methacrylic acid) and crosslinking monomers (methylene bisacrylamide and ethylene glycol dimethacrylate) were copolymerized in the presence of the AED template and grafted on the graphite particles by simple radical photopolymerization. The grafted particles were mixed with silicon oil, dissolving ferrocene as a redox marker to make the MIP-carbon paste (CP). Disposable sensor chips were fabricated by packing the MIP-CP into the base made of poly (ethylene glycol terephthalate) (PET) film. The sensor’s sensitivity was determined using differential pulse voltammetry (DPV), carried out on a single sensor chip for each operation. Linearity was obtained from 0–60 μg/mL in PB and LEV and 0–12 μg/mL in CBZ, covering their respective therapeutic range. The time taken for each measurement was around 2 min. The experiment using whole bovine blood and bovine plasma indicated that the existence of species that interfered had a negligible effect on the test’s sensitivity. This disposable MIP sensor provides a promising approach for point-of-care testing and facilitating the management of epilepsy. Compared with existing tests, this sensor offers a faster and more accurate way to monitor AEDs, which is crucial for optimizing therapy and improving patient outcomes. Overall, the proposed disposable sensor chip based on MIP-CPs represents a significant advancement in AED monitoring, with the potential for rapid, accurate, and convenient point-of-care testing.

1 March 2015 in Analytica Chimica Acta
Verified
Journal Article
Closed access
Yasuo YoshimiYasuo Yoshimi
Yasuo Yoshimi
NINoriyuki Ishii
Noriyuki Ishii